X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41) 41
index medicus (33) 33
male (31) 31
female (29) 29
middle aged (28) 28
adult (23) 23
hematology (22) 22
life sciences (22) 22
aged (21) 21
cancer (14) 14
retrospective studies (13) 13
young adult (13) 13
transplantation (12) 12
analysis (11) 11
chemotherapy (11) 11
prognosis (11) 11
stem cells (11) 11
transplantation, homologous (11) 11
adolescent (10) 10
hematopoietic stem cell transplantation (10) 10
oncology (10) 10
recurrence (10) 10
treatment outcome (10) 10
immunology (9) 9
leukemia (9) 9
mortality (9) 9
transplantation conditioning - methods (9) 9
disease-free survival (8) 8
mutation (8) 8
acute myeloid leukemia (7) 7
adults (7) 7
france (7) 7
hematopoietic stem cells (7) 7
survival analysis (7) 7
[sdv.can]life sciences [q-bio]/cancer (6) 6
abridged index medicus (6) 6
bone marrow (6) 6
follow-up studies (6) 6
human health and pathology (6) 6
medicine & public health (6) 6
mesh : female (6) 6
mesh : humans (6) 6
mesh : male (6) 6
aml (5) 5
antineoplastic agents (5) 5
antineoplastic agents - therapeutic use (5) 5
leukemia, myeloid, acute - mortality (5) 5
mesh : aged (5) 5
mesh: aged (5) 5
mesh: female (5) 5
mesh: humans (5) 5
mesh: male (5) 5
multivariate analysis (5) 5
risk (5) 5
survival rate (5) 5
therapy (5) 5
transplants & implants (5) 5
versus-host-disease (5) 5
[ sdv.imm ] life sciences [q-bio]/immunology (4) 4
aged, 80 and over (4) 4
anesthesiology (4) 4
blood (4) 4
clinical trials (4) 4
emergency medicine (4) 4
expression (4) 4
hematology, oncology and palliative medicine (4) 4
intensive / critical care medicine (4) 4
lymphocytes (4) 4
medical research (4) 4
medicine, general & internal (4) 4
mesh: middle aged (4) 4
morbidity (4) 4
myelodysplastic syndrome (4) 4
pharmacology & pharmacy (4) 4
registries (4) 4
remission induction (4) 4
research (4) 4
risk factors (4) 4
tissue donors (4) 4
[ sdv.can ] life sciences [q-bio]/cancer (3) 3
age factors (3) 3
antimitotic agents (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bone-marrow-transplantation (3) 3
cohort studies (3) 3
daunorubicin (3) 3
hematopoietic stem cell transplantation - adverse effects (3) 3
hemic and lymphatic diseases (3) 3
immunotherapy (3) 3
incidence (3) 3
leukemia, myeloid, acute - diagnosis (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
leukemia, myeloid, acute - therapy (3) 3
lymphomas (3) 3
medicine, experimental (3) 3
meeting abstracts (3) 3
mesh : aged, 80 and over (3) 3
mesh : hematopoietic stem cell transplantation (3) 3
mesh : middle aged (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9825, pp. 1508 - 1516
Journal Article
by Reignier, Jean and Boisramé-Helms, Julie and Brisard, Laurent and Lascarrou, Jean-Baptiste and Ait Hssain, Ali and Anguel, Nadia and Argaud, Laurent and Asehnoune, Karim and Asfar, Pierre and Bellec, Frédéric and Botoc, Vlad and Bretagnol, Anne and Bui, Hoang-Nam and Canet, Emmanuel and Da Silva, Daniel and Darmon, Michael and Das, Vincent and Devaquet, Jérôme and Djibre, Michel and Ganster, Frédérique and Garrouste-Orgeas, Maité and Gaudry, Stéphane and Gontier, Olivier and Guérin, Claude and Guidet, Bertrand and Guitton, Christophe and Herbrecht, Jean-Etienne and Lacherade, Jean-Claude and Letocart, Philippe and Martino, Frédéric and Maxime, Virginie and Mercier, Emmanuelle and Mercier, Romain and Mira, Jean-Paul and Nseir, Saad and Piton, Gael and Quenot, Jean-Pierre and Richecoeur, Jack and Rigaud, Jean-Philippe and Robert, René and Rolin, Nathalie and Schwebel, Carole and Sirodot, Michel and Tinturier, François and Thévenin, Didier and Giraudeau, Bruno and Le Gouge, Amélie and Dupont, Hervé and Pierrot, Marc and Beloncle, François and Combaux, Danièle and Winiszewski, Hadrien and Capellier, Gilles and Hilbert, Gilles and Gruson, Didier and Kalfon, Pierre and Souweine, Bertrand and Coupez, Elizabeth and Ricard, Jean-Damien and Messika, Jonathan and Bougerol, François and Declercq, Pierre-Louis and Dargent, Auguste and Large, Audrey and Annane, Djillali and Clair, Bernard and Bonadona, Agnès and Hamidfar, Rebecca and Richard, Christian and Henry-Lagarrigue, Mathieu and Yehia, Ahiem Yehia and Temime, Johanna and Barrailler, Stephanie and Favory, Raphaël and Parmentier-Decrucq, Erika and Jourdain, Mercé and Baboi, Loredana and Simon, Marie and Baudry, Thomas and Monchi, Mehran and Roustan, Jérôme and Bardou, Patrick and Cottereau, Alice and Guiot, Philippe and Brule, Noelle and Landais, Mickael and Roquilly, Antoine and Boulain, Thierry and Benzekri, Dalila and Champigneulle, Benoit and Tahiri, Jalel and Preda, Gabriel and Misset, Benoit and Lemiale, Virginie and Zafrani, Lara and Fartoukh, Muriel and Thiéry, Guillaume and Chatellier, Delphine and Coudroy, Rémi and Chouquer, Renaud and ... and NUTRIREA-2 Trial Investigators and Clinical Research in Intensive Care and Sepsis (CRICS) group
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10116, pp. 133 - 143
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 808 - 814
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 08/2017, Volume 318, Issue 6, pp. 557 - 566
IMPORTANCE: Bronchiolitis obliterans syndrome has been associated with increased morbidity and mortality after allogeneic hematopoietic stem cell transplant... 
MEDICINE, GENERAL & INTERNAL | LUNG TRANSPLANTATION | BRONCHIOLITIS OBLITERANS SYNDROME | THERAPY | EFFICACY | REJECTION | PULMONARY COMPLICATIONS | RISK | MICROBIOTA | LEUKEMIA | VERSUS-HOST-DISEASE | Hematologic Neoplasms - therapy | Recurrence | Double-Blind Method | Bronchiolitis Obliterans - etiology | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Transplantation, Homologous | Bronchiolitis Obliterans - prevention & control | Anti-Bacterial Agents - therapeutic use | Azithromycin - adverse effects | Disease-Free Survival | Azithromycin - therapeutic use | Treatment Failure | Hematopoietic Stem Cell Transplantation - adverse effects | Intention to Treat Analysis | Adult | Female | Anti-Bacterial Agents - adverse effects | Respiratory Function Tests | Transplantation Conditioning | Complications and side effects | Usage | Patient outcomes | Analysis | Lung diseases | Azithromycin | Stem cells | Dosage and administration | Transplantation | Pulmonary ventilation | Drug therapy | Risk factors | Respiratory function | Transplants & implants | Syngeneic grafts | Bronchopneumonia | Lung transplantation | Clinical trials | Stem cell transplantation | Malignancy | Incidence | Randomization | Motivation | Safety engineering | Bronchiolitis obliterans | Cell survival | Hematology | Mortality | Patients | Survival | Morbidity | Hemopoiesis | Air flow | Respiratory diseases | Pulmonary functions | Original Investigation | Research
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2000, Volume 343, Issue 11, pp. 750 - 758
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2018, Volume 93, Issue 3, pp. 416 - 423
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 8/2016, Volume 42, Issue 8, pp. 1248 - 1257
Journal Article
Journal Article
Journal Article